Anterior Ischemic Optic Neuropathy,AION
Conditions
Interventions
Control group:Compound Anisodine Injection + Wei's Huoxue Tongluo Granule Mimic
Experimental group:Wei's Huoxue Tongluo Granules + Sterile Water for Injection
Sponsors
Dongfang Hospital, Beijing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
40 Years to 80 Years
Inclusion criteria
Inclusion criteria: ?Age between 40-80 years old; ? Meet the diagnostic criteria for ischemic optic neuropathy; ? Conform to the diagnosis of Qi deficiency and blood stasis type; ? The course of the disease is more than 3 months; ? intraocular pressure <21mmHg; ? Voluntarily participate in this study and sign the informed consent.
Exclusion criteria
Exclusion criteria: ? The onset eye cannot cooperate with the OCTA examination; ? Those who are allergic to the drugs studied in this group; ? Combined with mental disorders and serious organic diseases; ? Those who participate in other ophthalmic clinical trials; ? Those who have other organic eye diseases, such as glaucoma, uveitis, eye trauma, etc., and need urgent treatment; ? Pregnant and lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| best corrected visual acuity,BCVA;capillary perfusion density; | — |
Secondary
| Measure | Time frame |
|---|---|
| blood flow index;retinal nerve fiber layer thickness;TCM Syndrome Score;visual field; | — |
Countries
CHINA
Contacts
Public ContactLiao Liang
Dongfang Hospital, Beijing University of Chinese Medicine
Outcome results
None listed